192 related articles for article (PubMed ID: 37168994)
1. Contezolid, a novel oxazolidinone antibiotic, may improve drug-related thrombocytopenia in clinical antibacterial treatment.
Li B; Liu Y; Luo J; Cai Y; Chen M; Wang T
Front Pharmacol; 2023; 14():1157437. PubMed ID: 37168994
[TBL] [Abstract][Full Text] [Related]
2. Case report: Successful treatment with contezolid in a patient with tuberculous meningitis who was intolerant to linezolid.
Xu Z; Zhang J; Guan T; Wan G; Jiang C; Lang L; Wang L
Front Med (Lausanne); 2023; 10():1224179. PubMed ID: 37928457
[TBL] [Abstract][Full Text] [Related]
3. Advances in contezolid: novel oxazolidinone antibacterial in Gram-positive treatment.
Zhang GX; Liu TT; Ren AX; Liang WX; Yin H; Cai Y
Infection; 2024 Jun; 52(3):787-800. PubMed ID: 38717734
[TBL] [Abstract][Full Text] [Related]
4. Tuberculosis patients with special clinical conditions treated with contezolid: three case reports and a literature review.
Wang J; Ma L
Front Med (Lausanne); 2023; 10():1265923. PubMed ID: 38162885
[TBL] [Abstract][Full Text] [Related]
5. Clinical Utility of Contezolid-Containing Regimens in 25 Cases of Linezolid-Intolerable Tuberculosis Patients.
Wang J; Nie W; Ma L; Li Q; Geng R; Shi W; Chu N
Infect Drug Resist; 2023; 16():6237-6245. PubMed ID: 37745897
[TBL] [Abstract][Full Text] [Related]
6. A Phase III multicentre, randomized, double-blind trial to evaluate the efficacy and safety of oral contezolid versus linezolid in adults with complicated skin and soft tissue infections.
Zhao X; Huang H; Yuan H; Yuan Z; Zhang Y
J Antimicrob Chemother; 2022 May; 77(6):1762-1769. PubMed ID: 35265985
[TBL] [Abstract][Full Text] [Related]
7. Nonclinical Evaluation of Antibacterial Oxazolidinones Contezolid and Contezolid Acefosamil with Low Serotonergic Neurotoxicity.
Wang W; Voss KM; Liu J; Gordeev MF
Chem Res Toxicol; 2021 May; 34(5):1348-1354. PubMed ID: 33913699
[TBL] [Abstract][Full Text] [Related]
8. Contezolid in complicated skin and soft tissue infection.
Kaul G; Dasgupta A; Chopra S
Drugs Today (Barc); 2022 Jul; 58(7):315-326. PubMed ID: 35851867
[TBL] [Abstract][Full Text] [Related]
9. Rare tuberculosis in recipients of allogeneic hematopoietic stem cell transplantation successfully treated with contezolid-a typical case report and literature review.
Li J; Yu Z; Jiang Y; Lao S; Li D
Front Cell Infect Microbiol; 2023; 13():1258561. PubMed ID: 37908760
[TBL] [Abstract][Full Text] [Related]
10. Preclinical toxicity evaluation of novel antibacterial contezolid acefosamil in rats and dogs.
Wang W; Li Z; Gordeev MF; Yuan H
J Appl Toxicol; 2024 May; 44(5):770-783. PubMed ID: 38237604
[TBL] [Abstract][Full Text] [Related]
11. Compassionate use of contezolid in a toddler with severe community-acquired pneumonia induced by staphylococcus aureus: a case report and follow-up.
Liu HY; Bi XF; Wang YJ; Xie FJ; Zhang H; Zhu YC; Zhang Y; Wang ZH; Wu D; Meng H; Lin YL; Liu LQ; Qiu SX; Gao Y; Kang K; Gao Y
Front Pediatr; 2024; 12():1321447. PubMed ID: 38384659
[TBL] [Abstract][Full Text] [Related]
12. In vivo pharmacodynamic study of contezolid acefosamil, a prodrug of contezolid for oral and intravenous administration.
Wang XK; Yu J; Xie CY; Hu XX; Nie TY; Li X; Wang PH; Li GQ; Yuan H; Yang XY; Li CR; You XF
J Antimicrob Chemother; 2023 Jul; 78(7):1632-1636. PubMed ID: 37202829
[TBL] [Abstract][Full Text] [Related]
13.
Wang S; Cai C; Shen Y; Sun C; Shi Q; Wu N; Zheng S; Qian J; Zhang R; Zhou H
Front Microbiol; 2021; 12():729900. PubMed ID: 34489919
[TBL] [Abstract][Full Text] [Related]
14. Oxazolidinone: A promising scaffold for the development of antibacterial drugs.
Yuan S; Shen DD; Bai YR; Zhang M; Zhou T; Sun C; Zhou L; Wang SQ; Liu HM
Eur J Med Chem; 2023 Mar; 250():115239. PubMed ID: 36893700
[TBL] [Abstract][Full Text] [Related]
15. Contezolid: First Approval.
Hoy SM
Drugs; 2021 Sep; 81(13):1587-1591. PubMed ID: 34365606
[TBL] [Abstract][Full Text] [Related]
16. Use of Contezolid for the Treatment of Refractory Infective Endocarditis in a Patient with Chronic Renal Failure: Case Report.
Zhao S; Zhang W; Zhang L; Zhang J; Li J; Si L; Ding Y; Li M; Song Y
Infect Drug Resist; 2023; 16():3761-3765. PubMed ID: 37333679
[TBL] [Abstract][Full Text] [Related]
17.
An H; Sun W; Liu X; Wang T; Qiao J; Liang J
Microbiol Spectr; 2023 Sep; 11(5):e0462722. PubMed ID: 37732805
[TBL] [Abstract][Full Text] [Related]
18. A Novel Oxazolidinone, Contezolid (MRX-I), Expresses Anti-Mycobacterium abscessus Activity
Guo Q; Xu L; Tan F; Zhang Y; Fan J; Wang X; Zhang Z; Li B; Chu H
Antimicrob Agents Chemother; 2021 Oct; 65(11):e0088921. PubMed ID: 34460305
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics and Disposition of Contezolid in Humans: Resolution of a Disproportionate Human Metabolite for Clinical Development.
Wu X; Meng J; Yuan H; Zhong D; Yu J; Cao G; Liu X; Guo B; Chen Y; Li Y; Shi Y; Gordeev MF; Wu J; Zhang J
Antimicrob Agents Chemother; 2021 Oct; 65(11):e0040921. PubMed ID: 34398672
[TBL] [Abstract][Full Text] [Related]
20.
Carvalhaes CG; Duncan LR; Wang W; Sader HS
Antimicrob Agents Chemother; 2020 Oct; 64(11):. PubMed ID: 32778552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
